Seres TherapeuticsMCRB
那斯達克 · USD
8.47
+0.25
(+3.04%)
收盤 02/14 04:59 (UTC+8)
02/14 04:59 (UTC+8)
Seres TherapeuticsMCRB
8.47
+0.25
(+3.04%)
財務數據
損益表
- 1.26
- 0.00
- 1.26
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -99.75
- 40650.00
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 351 | - | - | - | - | - | - | 126,325 | 310 | 126,473 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 351 | - | - | - | - | - | - | 126,325 | 310 | 126,473 |
營業費用 | 22,828 | 24,881 | - | 28,835 | 29,171 | - | 39,586 | 76,235 | 47,723 | 76,949 |
研發費用 | 12,616 | 12,939 | 11,821 | 12,841 | 16,459 | 20,083 | 21,702 | 51,306 | 28,253 | 46,792 |
推銷及管理費用 | 10,212 | 11,942 | 15,415 | 15,994 | 12,712 | 16,410 | 17,884 | 24,929 | 19,470 | 30,157 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -22,477 | -24,881 | -27,236 | -28,835 | -29,171 | -36,493 | -39,586 | 50,090 | -47,413 | 49,524 |
其他收入及費用 | 30,681 | 5,026 | 59,918 | 13,198 | -21,864 | 3,885 | 4,116 | 2,307 | 3,571 | 215 |
利息費用 | - | - | - | - | - | 7,492 | 4,663 | 10,708 | 4,012 | 3,187 |
稅前純益 | 8,204 | -19,855 | 32,682 | -15,637 | -51,035 | -40,100 | -40,133 | 41,689 | -47,854 | 46,552 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 8,204 | -19,855 | 32,682 | -15,637 | 88,776 | -32,870 | -40,133 | -41,248 | -47,854 | 46,552 |
基本每股稅後盈餘(元) | 0.94 | -2.27 | 0.19 | -0.09 | 0.58 | -0.22 | -0.27 | - | -0.37 | 0.36 |
稀釋每股稅後盈餘(元) | 0.93 | -2.28 | 0.19 | -0.10 | 0.60 | -0.22 | -0.27 | -0.32 | -0.02 | 0.38 |
基本平均股數(千股) | 8758.00 | 8743.00 | 174064.00 | 171341.00 | 152644.00 | 151512.00 | 146100.00 | - | 128289.00 | 127713.00 |
稀釋平均股數(千股) | 8771.00 | 8743.00 | 174294.00 | 171341.00 | 152644.00 | 151512.00 | 146100.00 | - | 128289.00 | 129844.00 |
還原基本每股稅後盈餘(元) | 0.94 | -2.27 | 3.76 | -0.09 | 11.63 | -4.34 | -5.49 | - | -7.40 | 7.20 |
還原稀釋每股稅後盈餘(元) | 0.93 | -2.28 | 3.75 | -2.10 | 11.91 | -4.32 | -5.49 | -6.40 | -0.38 | 7.60 |
還原基本平均股數(千股) | 8,758 | 8,743 | 8,703 | 171,341 | 7,632 | 7,575 | 7,305 | - | 6,414 | 6,385 |
還原稀釋平均股數(千股) | 8,771 | 8,743 | 8,714 | 171,341 | 7,632 | 7,575 | 7,305 | - | 6,414 | 6,492 |
EBITDA(千元) | 9,248 | -18,796 | 33,758 | -14,552 | 90,643 | -23,473 | -33,446 | -28,499 | -41,765 | 51,367 |